Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Modern drug discovery often involves screening small molecules for their ability to bind to a preselected protein target. Target-oriented syntheses of these small molecules, individually or as collections (focused libraries), can be planned effectively with retrosynthetic analysis. Drug discovery can also involve screening small molecules for their ability to modulate a biological pathway in cells or organisms, without regard for any particular protein target. This process is likely to benefit in the future from an evolving forward analysis of synthetic pathways, used in diversity-oriented synthesis, that leads to structurally complex and diverse small molecules. One goal of diversity-oriented syntheses is to synthesize efficiently a collection of small molecules capable of perturbing any disease-related biological pathway, leading eventually to the identification of therapeutic protein targets capable of being modulated by small molecules. Several synthetic planning principles for diversity-oriented synthesis and their role in the drug discovery process are presented in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
A new type of synthetic peptide library for identifying ligand-binding activity
Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M., & Knapp, R. J. (1991) · Nature · doi:10.1038/354082a0 · Cited by 1,802
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
Self-citationHoughten, R. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.5131 · Cited by 1,643
Geysen, H. M., Meloen, R. H., & Barteling, S. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3998 · Cited by 1,475
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
General method for rapid synthesis of multicomponent peptide mixtures
FURKA, Á., SEBESTYÉN, F., ASGEDOM, M., & DIBÓ, G. (1991) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1991.tb00765.x · Cited by 1,155
Peptoids: a modular approach to drug discovery.
Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., & Marlowe, C. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9367 · Cited by 953
Solid-phase organic reactions: A review of the recent literature
Hermkens, P. H. H., Ottenheijm, H. C. J., & Rees, D. (1996) · Tetrahedron · doi:10.1016/0040-4020(96)00216-5 · Cited by 480
Cited by
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Multicomponent Reactions with Isocyanides
Dömling, A., & Ugi, I. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u · Cited by 4,077
Galliford, C. V., & Scheidt, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701342 · Cited by 2,429
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
Wolber, G., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,954
Privileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
Self-citationModern Strategies in Electroorganic Synthesis
Yoshida, J.-I., Kataoka, K., Horcajada, R., & Nagaki, A. (2008) · Chemical Reviews · doi:10.1021/cr0680843 · Cited by 1,417
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Multicomponent Reaction Design in the Quest for Molecular Complexity and Diversity
Ruijter, E., Scheffelaar, R., & Orru, R. V. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006515 · Cited by 1,329
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Transition metal–catalyzed alkyl-alkyl bond formation: Another dimension in cross-coupling chemistry
Choi, J., & Fu, G. C. (2017) · Science · doi:10.1126/science.aaf7230 · Cited by 1,007
Dobson, C. M. (2004) · Nature · doi:10.1038/nature03192 · Cited by 1,003
Recent Developments in the Isonitrile‐Based Multicomponent Synthesis of Heterocycles
Zhu, J. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200390167 · Cited by 956
Plants and human health in the twenty-first century
Raskin, I., Ribnicky, D. M., Komarnytsky, S., Ilic, N., Poulev, A., Borisjuk, N., Brinker, A., Moreno, D. A., Ripoll, C., Yakoby, N., et al. (2002) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)02080-2 · Cited by 913
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Galloway, W. R. J. D., Isidro-Llobet, A., & Spring, D. R. (2010) · Nature Communications · doi:10.1038/ncomms1081 · Cited by 891
Recent developments in asymmetric multicomponent reactions
de Graaff, C., Ruijter, E., & Orru, R. V. A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15361k · Cited by 876
Synthetic Multivalent Ligands as Probes of Signal Transduction
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
Bissantz, C., Folkers, G., & Rognan, D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001044l · Cited by 740
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture
Gestwicki, J. E., Cairo, C. W., Strong, L. E., Oetjen, K. A., & Kiessling, L. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027184x · Cited by 706
Ji, H., Li, X., & Zhang, H. (2009) · EMBO reports · doi:10.1038/embor.2009.12 · Cited by 636
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
BCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
Synthesis at the molecular frontier
Wender, P. A., & Miller, B. L. (2009) · Nature · doi:10.1038/460197a · Cited by 579
Chen, X.-H., Wei, Q., Luo, S.-W., Xiao, H., & Gong, L.-Z. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905302f · Cited by 577
Mechanism-Based Profiling of Enzyme Families
Evans, M. J., & Cravatt, B. F. (2006) · Chemical Reviews · doi:10.1021/cr050288g · Cited by 564
Alcohols as Electrophiles in CC Bond‐Forming Reactions: The Hydrogen Autotransfer Process
Guillena, G., Ramón, D. J., & Yus, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603794 · Cited by 562
Towards the Optimal Screening Collection: A Synthesis Strategy
Nielsen, T. E., & Schreiber, S. L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703073 · Cited by 551
Self-citationGrozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., & Schreiber, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106779200 · Cited by 539
Self-citationStereodivergence in Asymmetric Catalysis
Krautwald, S., & Carreira, E. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b13340 · Cited by 527
Natürliche Pyrrolidinylspirooxindole als Vorlagen für die Entwicklung medizinischer Wirkstoffe
Galliford, C. V., & Scheidt, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200701342 · Cited by 524
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
Natural Product Hybrids as New Leads for Drug Discovery
Tietze, L. F., Bell, H. P., & Chandrasekhar, S. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200553 · Cited by 516
Small molecule developmental screens reveal the logic and timing of vertebrate development
Peterson, R. T., Link, B. A., Dowling, J. E., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.12965 · Cited by 486
Self-citationExploring biology with small organic molecules
Stockwell, B. R. (2004) · Nature · doi:10.1038/nature03196 · Cited by 470
Natural Organic Matter and the Event Horizon of Mass Spectrometry
Hertkorn, N., Frommberger, M., Witt, M., Koch, B. P., Schmitt-Kopplin, P., & Perdue, E. M. (2008) · Analytical Chemistry · doi:10.1021/ac800464g · Cited by 455
Recognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438
Diversity-oriented synthesis: producing chemical tools for dissecting biology
O' Connor, C. J., Beckmann, H. S. G., & Spring, D. R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35023h · Cited by 434
Chemical genetics: ligand-based discovery of gene function
Stockwell, B. R. (2000) · Nature Reviews Genetics · doi:10.1038/35038557 · Cited by 421
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Han, B., He, X.-H., Liu, Y.-Q., He, G., Peng, C., & Li, J.-L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00196a · Cited by 402
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Nadin, A., Hattotuwagama, C., & Churcher, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105840 · Cited by 390
Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries
Ertl, P., Roggo, S., & Schuffenhauer, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700286x · Cited by 387
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation
Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A., & Fishman, M. C. (2004) · Nature Biotechnology · doi:10.1038/nbt963 · Cited by 384
Self-citationGenerating Diverse Skeletons of Small Molecules Combinatorially
Burke, M. D., Berger, E. M., & Schreiber, S. L. (2003) · Science · doi:10.1126/science.1089946 · Cited by 375
Self-citationProspects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays
Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J., & Schreiber, S. L. (2002) · Nature · doi:10.1038/416653a · Cited by 367
Self-citationMolecular dynamics-driven drug discovery: leaping forward with confidence
Ganesan, A., Coote, M. L., & Barakat, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.001 · Cited by 357
Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
Garman, S. C., Wurzburg, B. A., Tarchevskaya, S. S., Kinet, J.-P., & Jardetzky, T. S. (2000) · Nature · doi:10.1038/35018500 · Cited by 355
Chemical space as a source for new drugs
Reymond, J.-L., van Deursen, R., Blum, L. C., & Ruddigkeit, L. (2010) · MedChemComm · doi:10.1039/c0md00020e · Cited by 347
Spring, D. R. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b310752n · Cited by 347
Molecular diversity of spirooxindoles. Synthesis and biological activity
Pavlovska, T. L., Redkin, R. G., Lipson, V. V., & Atamanuk, D. V. (2016) · Molecular Diversity · doi:10.1007/s11030-015-9629-8 · Cited by 346
Encoded self-assembling chemical libraries
Melkko, S., Scheuermann, J., Dumelin, C. E., & Neri, D. (2004) · Nature Biotechnology · doi:10.1038/nbt961 · Cited by 341
Natural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
Huigens III, R. W., Morrison, K. C., Hicklin, R. W., Flood Jr, T. A., Richter, M. F., & Hergenrother, P. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1549 · Cited by 320
Specific Labeling of Cell Surface Proteins with Chemically Diverse Compounds
George, N., Pick, H., Vogel, H., Johnsson, N., & Johnsson, K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048396s · Cited by 320
Autonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 317
How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment
Wang, R., & Wang, S. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010025x · Cited by 311
Kim, J., Kim, H., & Park, S. B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508343a · Cited by 308
Walsh, D. P., & Chang, Y.-T. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296
Wessjohann, L. A., Rivera, D. G., & Vercillo, O. E. (2009) · Chemical Reviews · doi:10.1021/cr8003407 · Cited by 293
Eine Strategie für die Diversitäts‐orientierte Synthese
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie · doi:10.1002/ange.200300626 · Cited by 291
Self-citationChen, C., Li, X., & Schreiber, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036558z · Cited by 289
Self-citationSmith, M. C., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 286
Diversity-oriented synthesis; a spectrum of approaches and results
Spandl, R. J., Bender, A., & Spring, D. R. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b719372f · Cited by 281
Strategies to diversify natural products for drug discovery
Li, G., & Lou, H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21474 · Cited by 278
A Library of Spirooxindoles Based on a Stereoselective Three-Component Coupling Reaction
Lo, M. M.-C., Neumann, C. S., Nagayama, S., Perlstein, E. O., & Schreiber, S. L. (2004) · Journal of the American Chemical Society · doi:10.1021/ja045089d · Cited by 276
Self-citationRoute to three-dimensional fragments using diversity-oriented synthesis
Hung, A. W., Ramek, A., Wang, Y., Kaya, T., Wilson, J. A., Clemons, P. A., & Young, D. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015271108 · Cited by 268
From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes
Strausberg, R. L., & Schreiber, S. L. (2003) · Science · doi:10.1126/science.1083395 · Cited by 260
Self-citationTargeted Delivery of Multifunctional Magnetic Nanoparticles
McCarthy, J. R., Kelly, K. A., Sun, E. Y., & Weissleder, R. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.153 · Cited by 255
Ertl, P., Jelfs, S., Mühlbacher, J., Schuffenhauer, A., & Selzer, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060217p · Cited by 254
Lehár, J., Stockwell, B. R., Giaever, G., & Nislow, C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.120 · Cited by 172
Zhu, H., Zhang, J., Kim, M. T., Boison, A., Sedykh, A., & Moran, K. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500145h · Cited by 154
Natural products as antifungal agents against clinically relevant pathogens
Di Santo, R. (2010) · Natural Product Reports · doi:10.1039/b914961a · Cited by 115
Haggarty, S. J., Clemons, P. A., & Schreiber, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja035413p · Cited by 61
Self-citation
Metadata
- Authors
- Schreiber, S. L.
- Venue
- Science
- Published
- 2000-03-17
- Volume
- 287
- Issue
- 5460
- Pages
- 1964-1969
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2090863707
- Cited by
- 2,568
- References
- 18
- FWCI
- 26.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.